Developing pathways to clarify pathogenicity of unclassified variants in Osteogenesis Imperfecta genetic analysis.
Meena BalasubramanianEmma HobsonMars SkaeJanine McCaugheyDavid J StephensPublished in: Molecular genetics & genomic medicine (2019)
Access to genetic testing in OI is increasing as advances in genetic technologies decreases cost; a clinical diagnostic pathway needs to be implemented for managing variants identified by such testing.